CD8A and neoplasm: The CD8+ T cell reduction and the inhibition of the cytokine production by SB may limit the beneficial SB induced proapoptotic effects on cancer cells through the suppression of CD8+ T cells, which may be insufficient in fighting against tumor cells without the required cytokine features.